Skip to Content

2nd Annual NASH Summit 2018

Start Date:
Monday, 23 April, 2018
End Date:
Wednesday, 25 April, 2018 6:00pm
Internal Medicine

As the industry's most comprehensive NASH forum, the NASH Summit returns with an unrivalled depth and breadth of cutting-edge NASH science from drug discovery through to late stage clinical development. Across 3 parallel streams of learning, 48 expert speakers including Gilead, Allergan and Novartis will share advances in: . Validating non-invasive biomarkers to confidently stratify patients and enhance clinical response.

Evaluating the scientific rationale behind combination therapy for more effective treatment. Conclusively comparing in vitro and in vivo models to better recapitulate human NASH and confidently progress into the clinic Join 150+ drug developers from 120+ organizations at this focused discussion and networking forum. Address this huge unmet clinical need and gain actionable insights to propel your candidate to therapeutic success. URL: Brochure: Prices: Conference Only: USD 2599, Workshop Only: USD 699 Speakers: Jason Campagna (Intercept Pharmaceuticals), Philip Just Larsen (Sanofi), Jamie Bates (Gilead Sciences), Dean Hurn (Genfit), Edgar Charles (Bristol-Myers Squibb)


Revere Hotel Boston Common,
200 Stuart Street,
United States

Organizer Details

Conference organized by Hanson Wade


Medical conference data provided by Meetings4Docs | Report a problem